We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+10.39%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.43B
AUM Growth
+$112M
Cap. Flow
+$19.8M
Cap. Flow %
0.82%
Top 10 Hldgs %
44.17%
Holding
71
New
12
Increased
26
Reduced
26
Closed
7

Top Buys

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$54.8M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$38.3M
3
TMO icon
Thermo Fisher Scientific
TMO
+$32M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$25.1M
5
PTCT icon
PTC Therapeutics
PTCT
+$23.9M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$50.2M
2
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$25.3M
3
MDVN
MEDIVATION, INC.
MDVN
+$24.8M
4
MRK icon
Merck
MRK
+$23.2M
5
CELG
Celgene Corp
CELG
+$22.2M

Sector Composition

Rank Sector Weight
1 Healthcare 92.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$323B
$37.9M 1.56%
699,579
-447,649
-39% -$23.2M
ILMN icon
27
Illumina
ILMN
$28.7B
$36.4M 1.5%
251,849
+35,261
+16% +$5.18M
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
$34.2M 1.41%
493,400
+21,000
+4% +$1.54M
PTLA
29
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$31.4M 1.29%
1,212,245
+210,431
+21% +$5.62M
MNK
30
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$28.7M 1.18%
452,764
-1,600
-0.4% -$101K
FRX
31
DELISTED
FOREST LABORATORIES INC
FRX
$24.9M 1.03%
+270,100
New +$21.8M
CLDX icon
32
Celldex Therapeutics
CLDX
$2.8B
$24.9M 1.02%
93,927
-54,586
-37% -$20.9M
PTCT icon
33
PTC Therapeutics
PTCT
$6.29B
$24.8M 1.02%
947,902
+890,383
+1,548% +$23.9M
ICPT
34
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$24.6M 1.01%
+74,493
New +$25.1M
SGNT
35
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$24.3M 1%
1,038,504
+348,775
+51% +$7.63M
INSM icon
36
Insmed
INSM
$22.7B
$22.3M 0.92%
1,172,121
-320,000
-21% -$6.08M
UTHR icon
37
United Therapeutics
UTHR
$26.3B
$22M 0.91%
234,400
+52,400
+29% +$5.36M
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
$20.2M 0.83%
442,819
+20,300
+5% +$971K
RDY icon
39
Dr. Reddy's Laboratories
RDY
$9.8B
$18.9M 0.78%
2,158,060
-12,890
-0.6% -$112K
BHC icon
40
Bausch Health
BHC
$1.67B
$17M 0.7%
+128,800
New +$17.6M
AKRX
41
DELISTED
Akorn Inc
AKRX
$16.8M 0.69%
761,443
-126,039
-14% -$2.95M
COV
42
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$15.5M 0.64%
209,876
-152,603
-42% -$10.6M
ISRG icon
43
Intuitive Surgical
ISRG
$128B
$14.2M 0.58%
291,672
-299,853
-51% -$14.1M
ABBV icon
44
AbbVie
ABBV
$454B
$14.1M 0.58%
273,979
-198,693
-42% -$10M
BSX icon
45
Boston Scientific
BSX
$67.6B
$13.8M 0.57%
1,019,221
-1,082,384
-52% -$14.2M
MNTA
46
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$12.9M 0.53%
1,110,797
+216,101
+24% +$3.66M
ALGN icon
47
Align Technology
ALGN
$12B
$10.2M 0.42%
197,072
-123,975
-39% -$6.94M
TRNX
48
DELISTED
TORNIER N V SHARES (NLD)
TRNX
$9.4M 0.39%
442,801
-130,520
-23% -$2.53M
HTWR
49
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$9.31M 0.38%
99,241
-66,434
-40% -$6.46M
NXTM
50
DELISTED
NxStage Medical Inc.
NXTM
$6.33M 0.26%
496,465
-256,969
-34% -$3.35M
1
2
3

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Sectoral Asset Management held 71 positions worth $2.43B, up 4.8% from $2.32B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sectoral Asset Management's Q1 2014 filing shows 12 new, 26 increased, 26 reduced and 7 closed positions. Its largest new stake was Aegerion Pharmaceuticals: 934,100 shares worth $43.1M. The largest sale was Perrigo, an estimated $50.2M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 90% a quarter earlier.

  • Sectoral Asset Management's largest Q1 2014 buy was Aegerion Pharmaceuticals: 934,100 shares worth $43.1M.
  • Sectoral Asset Management added most to Teva Pharmaceuticals in Q1 2014, an estimated $38.3M increase.
  • Sectoral Asset Management's biggest Q1 2014 reduction was SYNAGEVA BIOPHARMA CORP COM STK (DE), cutting an estimated $25.3M.
  • Sectoral Asset Management fully exited Perrigo in Q1 2014, selling an estimated $50.2M.
  • Sectoral Asset Management's ten largest holdings make up 44% of its $2.43B portfolio in Q1 2014.
  • Sectoral Asset Management opened 12 new positions and closed 7 in Q1 2014.
  • Sectoral Asset Management's portfolio value rose 4.8% quarter-over-quarter to $2.43B.

Based on Sectoral Asset Management's 13F filing for Q1 2014, filed 14 May 2014.